Carlson J R, Yee J, Hinrichs S H, Bryant M L, Gardner M B, Pedersen N C
J Clin Microbiol. 1987 Mar;25(3):494-7. doi: 10.1128/jcm.25.3.494-497.1987.
There was 100% agreement between the results of indirect immunofluorescence (IF) and Western blot testing when these methods were used to detect antibodies to the human immunodeficiency virus in sera from 25 patients with acquired immune deficiency syndrome (AIDS), 20 patients with AIDS-related complex, 186 subjects at high risk for AIDS, and 40 healthy heterosexuals. However, there was only an 88.7% correlation between IF and Western blot results for 728 sera from blood and plasma donor centers that were selected on the basis of screening enzyme immunoassay reactivity. IF tests yielded nine false-negatives and were equivocal, yielding a nonspecific pattern of reactivity for both infected and uninfected cells for 73 of these specimens. The IF and Western blot methods were equal in performance for the detection of anti-human immunodeficiency virus antibodies in the high-risk and unselected low-risk groups, proving to be a practical approach for testing specimens from these subjects. However, the Western blot was the most acceptable method for the validation of specimens from groups at low risk for AIDS that were selected based on enzyme immunoassay reactivity.
当使用间接免疫荧光法(IF)和蛋白质印迹法检测25例获得性免疫缺陷综合征(AIDS)患者、20例AIDS相关综合征患者、186例AIDS高危人群以及40例健康异性恋者血清中的人类免疫缺陷病毒抗体时,两种方法的检测结果完全一致。然而,对于根据酶免疫测定反应性筛选出的728份来自血液和血浆供血中心的血清样本,IF法与蛋白质印迹法结果之间的相关性仅为88.7%。IF检测出现了9例假阴性结果,并且有73份样本结果不明确,在感染和未感染细胞中均产生了非特异性反应模式。在高危组和未筛选的低危组中,IF法和蛋白质印迹法检测抗人类免疫缺陷病毒抗体的性能相当,证明是检测这些受试者样本的实用方法。然而,蛋白质印迹法是验证基于酶免疫测定反应性筛选出的AIDS低危组样本的最可接受方法。